Polynovo Ltd (ASX: PNV) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Polynovo Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $1.51 billion
P/E Ratio 856.00
Dividend Yield 0.00%
Shares Outstanding 690.23 million
Earnings per share 0.003
Dividend per share N/A
Year To Date Return 29.31%
Earnings Yield 0.12%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Polynovo Ltd (ASX: PNV)
    Latest News

    a woman
    Share Gainers

    Why Domino's, Opthea, Orocobre, & PolyNovo shares are storming higher

    The Domino's Pizza Enterprises Ltd (ASX:DMP) share price and the PolyNovo Ltd (ASX:PNV) share price are two of four storming…

    Read more »

    a woman
    Share Gainers

    PolyNovo share price jumps 12% on strong sales update

    The PolyNovo Ltd (ASX:PNV) share price is racing higher on Tuesday after the release of a strong sales update...

    Read more »

    a woman
    Share Market News

    How will 2019's best ASX 200 shares perform in 2020?

    In 2019 the ASX 200 increased nearly 22%, with a number of shares posting huge gains. Here we take a…

    Read more »

    a woman
    Share Market News

    ALL ORDINARIES finishes higher Wednesday: 8 ASX shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished up on Wednesday, here are 8 ASX shares you missed.

    Read more »

    a woman
    Share Fallers

    Why Perenti, Perseus, Polynovo, & Sezzle shares are tumbling lower

    The Perenti Global Ltd (ASX:PRN) share price and the Sezzle Inc (ASX:SZL) share price are two of four tumbling lower…

    Read more »

    a woman
    Share Market News

    ASX 200 lunch update: Afterpay, REA Group, & WiseTech higher

    Afterpay Ltd (ASX:APT), Pilbara Minerals Ltd (ASX:PLS), and REA Group Limited (ASX:REA) shares are making a splash on the ASX…

    Read more »

    a woman
    Share Gainers

    These were the best performing ASX 200 shares in 2019

    AVITA Medical Ltd (ASX:AVH) and Fortescue Metals Group Limited (ASX:FMG) were amongst the best performers on the ASX 200 in…

    Read more »

    a woman
    ⏸️ Investing

    3 ASX healthcare shares with healthy returns this year

    Led by CSL Limited (ASX: CSL), the S&P/ASX 200 Healthcare Index (ASX: XHJ) is up over 42% for the year.…

    Read more »

    a woman
    Share Gainers

    Why the CogState share price is surging higher today

    The CogState Limited (ASX: CGS) share price surged after the brain health testing company reported a record level of sales…

    Read more »

    a woman
    Share Gainers

    These ASX 200 shares have been on fire in 2019

    Avita Medical Ltd (ASX:AVH) shares are one of three on the ASX 200 that have been rocketing higher in 2019...

    Read more »

    a woman
    Share Market News

    ALL ORDINARIES finishes higher Friday: 8 ASX shares you missed

    The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) finished up on Friday, here are 8 ASX shares you missed.

    Read more »

    a woman
    Share Gainers

    Why AP Eagers, Appen, Bravura, & Polynovo shares are pushing higher today

    The Bravura Solutions Ltd (ASX:BVS) share price and the Polynovo Ltd (ASX:PNV) share price are two of four pushing higher…

    Read more »

    Frequently Asked Questions

    The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was listed on the ASX  on 26 November 1998 and is headquartered in Melbourne.

    No, the company does not historically pay dividends.

    PNV ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Polynovo Ltd

    PolyNovo Ltd (ASX: PNV) develops and commercialises innovative medical devices using its patented NovoSorb technology.

    NovoSorb is a family of biocompatible polymers that are used in the treatment of burns and surgical wounds. They biodegrade into by-products that can be absorbed and excreted by the body. For example, its NovoSorb BTM (Biodegradable Temporising Matrix) can be used to temporarily close a wound and aid the body in generating new tissue.

    PolyNovo’s products are sold across Australia and New Zealand, the United States, the United Kingdom, and Europe.

    PNV Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    27 Mar 2024 $2.14 $0.04 1.90% 1,793,957 $2.12 $2.22 $2.11
    26 Mar 2024 $2.10 $-0.02 -0.94% 6,338,523 $2.10 $2.12 $2.06
    25 Mar 2024 $2.12 $-0.01 -0.47% 2,646,839 $2.15 $2.16 $2.09
    22 Mar 2024 $2.13 $-0.07 -3.18% 1,118,356 $2.18 $2.19 $2.10
    21 Mar 2024 $2.20 $0.06 2.80% 2,071,350 $2.19 $2.24 $2.17
    20 Mar 2024 $2.14 $-0.05 -2.28% 1,883,237 $2.21 $2.25 $2.12
    19 Mar 2024 $2.19 $-0.16 -6.81% 2,478,168 $2.37 $2.39 $2.17
    18 Mar 2024 $2.35 $0.02 0.86% 1,183,680 $2.31 $2.36 $2.30
    15 Mar 2024 $2.33 $0.01 0.43% 2,641,536 $2.30 $2.35 $2.22
    14 Mar 2024 $2.32 $-0.17 -6.83% 2,344,276 $2.51 $2.51 $2.30
    13 Mar 2024 $2.49 $0.01 0.40% 1,851,249 $2.49 $2.52 $2.46
    12 Mar 2024 $2.48 $0.08 3.33% 3,173,551 $2.42 $2.52 $2.41
    11 Mar 2024 $2.40 $0.01 0.42% 1,306,415 $2.39 $2.44 $2.37
    08 Mar 2024 $2.39 $0.10 4.37% 3,030,795 $2.30 $2.41 $2.27
    07 Mar 2024 $2.29 $0.04 1.78% 1,609,829 $2.29 $2.30 $2.27
    06 Mar 2024 $2.25 $0.01 0.45% 1,564,337 $2.23 $2.26 $2.17
    05 Mar 2024 $2.24 $0.03 1.36% 1,531,840 $2.22 $2.25 $2.16
    04 Mar 2024 $2.21 $0.01 0.45% 2,194,703 $2.27 $2.30 $2.14
    01 Mar 2024 $2.20 $-0.08 -3.51% 2,227,886 $2.25 $2.25 $2.16
    29 Feb 2024 $2.28 $0.15 7.04% 3,585,967 $2.10 $2.28 $2.08
    28 Feb 2024 $2.13 $0.15 7.56% 6,081,790 $2.02 $2.19 $2.01
    27 Feb 2024 $1.99 $-0.03 -1.49% 1,765,142 $2.01 $2.03 $1.94

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    31 Oct 2023 Robyn Elliott Buy 32,000 $38,080
    On-market trade.
    28 Jun 2023 Robyn Elliott Buy 27,000 $39,690
    On-market trade.
    08 Jun 2023 David Williams Buy 22,500 $36,000
    On-market trade.
    07 Jun 2023 David Williams Buy 14,453 $23,448
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Williams Non-Executive DirectorNon-Executive Chairman Feb 2014
    Mr Williams was appointed as a Non-executive Director on 28 February 2014 and Chairman on 13 March 2014. Mr Williams is an experienced Director and investment banker with a track record in business development as well as in mergers and acquisitions and capital raising.
    Mr Bruce Rathie Non-Executive Director Feb 2010
    Mr Rathie was appointed a Director of PolyNovo on 18 February 2010. He is an experienced Company Director with a finance and legal background. He practised as a partner in a legal firm and acted as Senior Corporate Counsel to Bell Resources Limited.
    Dr Robyn Elliott Non-Executive Director Oct 2019
    Dr Elliott was appointed a Director of PolyNovo on 28 October 2019. Dr Elliott is currently Global Head, Strategic Portfolio Management at CSL Behring. Dr Elliott previously held Strategic Expansion and Quality Senior Director roles within CSL, was the Managing Director at IDT Australia and commenced her career at DBL Faulding.
    Mr Andrew Stuart Lumsden Non-Executive Director Jun 2021
    Mr Lumsden was appointed a Director of PolyNovo on 4 June 2021. He has more than 20 years' experience locally and internationally. Mr Lumsden is currently Chief Executive Officer of Wellcom Worldwide Australasia having previously held the roles of Group Chief Financial Officer and Group Chief Operating Officer.
    Mr Leon Hoare Non-Executive Director Jan 2016
    Mr Hoare was appointed a Director of PolyNovo on 27 January 2016. He is currently the Managing Director of Lohmann & Rauscher, Australia & New Zealand (ANZ), a private EU based medical device company. Previously he was Managing Director of Smith & Nephew ANZ (all divisions) until 2015. He served as President of Smith & Nephew's Asia-Pacific Advanced Wound Management (AWM) businesses for 5 years and was a member of the Global Executive Management for the AWM Division.
    Ms Christine Emmanuel-Donnelly Non-Executive Director May 2020
    Ms Emmanuel-Donnelly was appointed a Director of PolyNovo on 13 May 2020. She has more than 30 years' local and international experience. She is Vice President of the Board of the Institute of Patent and Trade Mark Attorneys of Australia on Springboard Enterprises Life Sciences Council, is a non-executive director on the board of Medical Developments International and is a member of the Australian Institute of Company Directors.
    Mr Jan-Marcel Gielen Chief Financial OfficerCompany Secretary Dec 2018
    -
    Mr Swami Raote Chief Executive Officer Jul 2022
    -
    Swami Raote Chief Executive Officer
    -
    Jan-Marcel Gielen Chief Financial OfficerCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 94,468,202 13.69%
    J P Morgan Nominees Australia Pty Limited 58,519,477 8.48%
    Citicorp Nominees Pty Limited 26,811,635 3.88%
    Moggs Creek Pty Ltd (Moggs Creek Super A/C) 19,010,112 2.75%
    BNP Paribas Noms Pty Ltd (Drp) 12,383,050 1.79%
    Lateral Innovations Pty Ltd (Trust A/C) 10,924,103 1.58%
    National Nominees Limited 8,413,960 1.22%
    Mr Anthony Shane Kittel + Mrs Michele Therese Kittel (Kittel Family Super A/C) 8,055,789 1.17%
    BNP Paribas Nominees Pty Ltd (Ib Au Noms Retailclient Drp) 5,909,896 0.86%
    Sandhurst Trustees Ltd (Endeavor Asset Mgmt Mda A/C) 5,739,049 0.83%
    Netwealth Investments Limited (Wrap Services A/C) 4,276,587 0.62%
    Ms Simone Maree Beks 4,185,095 0.61%
    Mr Paul Gerard Brennan 4,185,095 0.61%
    Commonwealth Scientific And Industrial Research Organisation 4,081,250 0.59%
    Mr Matthew James Avery 3,631,338 0.53%
    Mrs Li-Hsien Tsai 3,292,698 0.48%
    Mr David Kenley 3,139,855 0.45%
    Dr Marcus James Dermot Wagstaff + Mrs Lara Kate Wagstaff 3,072,166 0.45%
    Mr Laurent Fossaert 2,929,961 0.42%
    MR CHRIS DAWBORN (HASKALI SUPER FUND A/C) 2,870,271 0.42%

    Profile

    since

    Note